Appropriateness of initial dose of non-vitamin K antagonist oral anticoagulants in patients with non-valvular atrial fibrillation in the UK
Objective To evaluate the appropriateness of the initial prescribed daily dose of non-vitamin K antagonist oral anticoagulants (NOACs) according to label in patients with non-valvular atrial fibrillation (NVAF) in the UK.Design Population-based cross-sectional study.Setting UK primary care.Populatio...
Saved in:
| Main Authors: | Mar Martín-Pérez, Luis Alberto García Rodríguez, Pareen Vora, Luke Roberts, Yanina Balabanova, Gunnar Brobert, Samuel Fatoba, Kiliana Suzart-Woischnik, Bernhard Schaefer, Ana Ruigomez |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2019-09-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/9/9/e031341.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of the anticoagulant effect of vitamin K antagonists in patients with non-valvular atrial fibrilation
by: Stanojković Zoran, et al.
Published: (2020-01-01) -
Challenges and lessons learned from a long-term postauthorisation safety study programme of rivaroxaban in Europe
by: Luis Alberto García Rodríguez, et al.
Published: (2024-03-01) -
Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation in Real Clinical Practice: in Appropriate Dose Reductions
by: V. A. Ionin, et al.
Published: (2021-05-01) -
Cost-effectiveness of direct oral anticoagulants in non-valvular atrial fibrillation
by: Inigo Gorostiza, et al.
Published: (2025-01-01) -
Meta-analysis of real-world evidence comparing non-vitamin K antagonist oral anticoagulants with vitamin K antagonists for the treatment of patients with non-valvular atrial fibrillation
by: Craig I. Coleman, et al.
Published: (2019-01-01)